The influence of donor KIR repertoire on the clinical outcome after unrelated, T-cell depleted HSCT for patients with AML

被引：0
|
作者：
Schellekens, J. [1 ]
Shaw, B. E. [1 ]
Mayor, N. P. [1 ]
Cooke, L. [1 ]
Perry, J. [2 ]
Pearce, R. M. [2 ]
Wilson, M. [2 ]
Kirkland, K. E. [2 ]
Potter, M. N. [3 ]
Russell, N. H. [4 ]
Pagliuca, A. [5 ]
Madrigal, J. A. [1 ]
Marsh, S. G. E. [1 ]
机构：
[1] Anthony Nolan Res Inst, London, England
[2] British Soc Blood & Marrow Transplantat Data Regi, London, England
[3] Royal Marsden Hosp, Surrey, GB, England
[4] Univ Nottingham Hosp, Nottingham NG7 2UH, GB, England
[5] Kings Coll Hosp, London, England
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [1] THE INFLUENCE OF PATIENT AND DONOR KIR HAPLOTYPES ON THE CLINICAL OUTCOME AFTER UNRELATED DONOR HSCT FOR PATIENTS SUFFERING FROM AML
    Schellekens, Jennifer
    Shaw, Bronwen E.
    Mayor, Neema P.
    Cooke, Louise
    Madrigal, J. Alejandro
    Marsh, Steven G. E.
    TISSUE ANTIGENS, 2012, 79 (06): : 467 - 467
  • [2] Alternative donor selection including KIR genotype repertoire: improved clinical outcome after unrelated HSCT
    Schellekens, J.
    Rozemuller, E. H.
    Alberink, A. M.
    van den Tweel, J. G.
    Petersen, E. J.
    Verdonck, L. F.
    Tilanus, M. G. J.
    TISSUE ANTIGENS, 2007, 69 (05): : 385 - 385
  • [3] Donor activating KIR genes significantly influence relapse in leukemia patients after myeloablative conditioning followed by in-vivo T-CELL depleted [ATG] unrelated stem cell transplantation
    Kroeger, Nicolaus
    Binder, Thomas
    Zabelina, Tatjana
    Schieder, Heike
    Renges, Helmut
    Ayuk, Francis
    Wolschke, Christine
    Eiermann, Thomas
    Zander, Axel R.
    ANNALS OF HEMATOLOGY, 2006, 85 : 26 - 27
  • [4] Unrelated Donor T-Cell Depleted (TCD) Hematopoietic Stem Cell Transplantation (HSCT) for Patients with Advanced Myelodysplastic Syndromes (MDS): The MSKCC Experience
    Chung, Stephen S.
    Goldberg, Jenna D.
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    Devlin, Sean
    Boulad, Farid
    Perales, Miguel
    Kernan, Nancy A.
    Ponce, Doris M.
    Small, Trudy N.
    Koehne, Guenther
    Barker, Juliet N.
    O'Reilly, Richard J.
    Giralt, Sergio A.
    van den Brink, Marcel R. M.
    Young, James W.
    Castro-Malaspina, Hugo R.
    BLOOD, 2012, 120 (21)
  • [5] Characterization of the T-cell Repertoire after Autologous HSCT in Patients with Ankylosing Spondylitis
    Komech, E. A.
    Zvyagin, I. V.
    Pogorelyy, M. V.
    Mamedov, I. Z.
    Fedorenko, D. A.
    Lebedev, Y. B.
    ACTA NATURAE, 2018, 10 (02): : 48 - 57
  • [6] The Effect of the CASP8-6526N Del Promoter Polymorphism on Outcome in T-Cell Depleted Unrelated Donor Haemopoetic Stem Cell Transplants (HSCT)
    Krishnamurty, Suchitra
    Shaw, Bronwen E.
    Byrne, J. L.
    Seedhouse, C.
    Mayor, Neeina P.
    Madrigal, A. J.
    Russell, Nigel H.
    BLOOD, 2008, 112 (11) : 1032 - 1032
  • [7] Donor activating KIR influence outcome post unrelated stem cell transplantation
    Bishara, A
    De Santis, D
    Brautbar, C
    Witt, C
    Nagler, A
    Slavin, S
    Christiansen, F
    HUMAN IMMUNOLOGY, 2004, 65 : S17 - S17
  • [8] ADENOVIRUS VIREMIA IN PATIENTS WITH CLINICAL SYMPTOMS AFTER T-CELL DEPLETED HSCT: RATES OF ADENOVIRUS DISEASE AND OUTCOMES
    Lee, Y. J.
    Chung, D.
    Xiao, K.
    Small, T.
    Papadopoulos, E.
    Jakubowski, A. A.
    Papanicolaou, G. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S214 - S215
  • [9] Increased Risk of for Cytomegalovirus Reactivation after Allogeneic HSCT in T-Cell Depleted Patients
    Molla, Vinicius Campos
    Azevedo, Roberta
    Ramos, Jessica Fernandes
    Ponciano, Danilo Belchior
    de Moraes, Pedro Henrique Arruda
    Da Fonseca, Ana Rita
    Seiwald, Maria Cristina Nunez
    Serpa, Mariana
    Ferreira, Aliana Meneses
    Szor, Roberta Shcolnik
    Leonel, Rayana Bomfim
    Xavier, Erick Menezes
    Rocha, Vanderson
    Tucunduva, Luciana
    Novis, Yana
    Nucci, Marcio
    Kallas, Esper
    Arrais, Celso
    BLOOD, 2020, 136
  • [10] T-cell reconstitution after haplo-identical PBSCT Is delayed, comparable with recovery after T-cell depleted unrelated donor BMT but not non-T-cell depleted BMT
    Ball, LM
    Jol-van der Zljde, CM
    Steggerda, SJ
    Lankester, AC
    Bredius, RGM
    Kurpershoek, T
    Egeler, RM
    Vossen, JM
    van Tol, MJ
    BONE MARROW TRANSPLANTATION, 2002, 29 : S4 - S5
12345